three new ORAL drugs for multiple sclerosis... 4-aminopyridine, cladribine, and fingolimod

March 2010

Patients will be asking about three new ORAL drugs for multiple sclerosis....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Gastroenterology Should patients stop taking low-dose aspirin after a GI bleed
health care professionals are asking how they can donate medications for an emergency
Smoking Cessation patients with cardiovascular disease using Champix (varenicline) to stop smoking
New guidelines will emphasize prevention and control of mumps outbreaks
Pediatrics new drug for ADHD, Vyvanse (lisdexamfetamine)
Diabetes Metformin or glyburide will be used more for gestational diabetes
Infectious Diseases appropriate antibiotic choices for complicated intra-abdominal infections
Substance Use Disorder There's concern about people abusing clonidine
Natural Health Products whether saw palmetto is effective for benign prostatic hyperplasia (BPH)
Nitrates how to choose a long-acting nitrate product
Multiple Sclerosis three new ORAL drugs for multiple sclerosis... 4-aminopyridine, cladribine, and fingolimod
Ophthalmology when to worry about drug or disease interactions with beta-blocker EYEDROPS for glaucoma
Cardiology whether Avandia (rosiglitazone) increases heart attack risk